These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 28624993)

  • 1. Cancer stem cell marker glycosylation: Nature, function and significance.
    Mallard BW; Tiralongo J
    Glycoconj J; 2017 Aug; 34(4):441-452. PubMed ID: 28624993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of cancer stem cells from different grades of human colorectal cancer.
    Manhas J; Bhattacharya A; Agrawal SK; Gupta B; Das P; Deo SV; Pal S; Sen S
    Tumour Biol; 2016 Oct; 37(10):14069-14081. PubMed ID: 27507615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas.
    Kure S; Matsuda Y; Hagio M; Ueda J; Naito Z; Ishiwata T
    Int J Oncol; 2012 Oct; 41(4):1314-24. PubMed ID: 22824809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of glyco-biomakers and glycan profiles in cancer stem cells.
    Pujari R; Dubey SK
    Glycobiology; 2024 Apr; 34(6):. PubMed ID: 36864577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface markers of hepatocellular cancer stem cells and their clinical potential.
    Feng D; Wang N; Hu J; Li W
    Neoplasma; 2014; 61(5):505-13. PubMed ID: 24712843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD49f-positive cell population efficiently enriches colon cancer-initiating cells.
    Haraguchi N; Ishii H; Mimori K; Ohta K; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
    Int J Oncol; 2013 Aug; 43(2):425-30. PubMed ID: 23708747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional repression of cancer stem cell marker CD133 by tumor suppressor p53.
    Park EK; Lee JC; Park JW; Bang SY; Yi SA; Kim BK; Park JH; Kwon SH; You JS; Nam SW; Cho EJ; Han JW
    Cell Death Dis; 2015 Nov; 6(11):e1964. PubMed ID: 26539911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface markers of cancer stem cells in solid tumors.
    Xia P
    Curr Stem Cell Res Ther; 2014 Mar; 9(2):102-11. PubMed ID: 24359139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosylation of Cancer Stem Cells: Function in Stemness, Tumorigenesis, and Metastasis.
    Barkeer S; Chugh S; Batra SK; Ponnusamy MP
    Neoplasia; 2018 Aug; 20(8):813-825. PubMed ID: 30015157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD26 a cancer stem cell marker and therapeutic target.
    Davies S; Beckenkamp A; Buffon A
    Biomed Pharmacother; 2015 Apr; 71():135-8. PubMed ID: 25960228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer stem cells (CSCs), cervical CSCs and targeted therapies.
    Huang R; Rofstad EK
    Oncotarget; 2017 May; 8(21):35351-35367. PubMed ID: 27343550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.
    Zakaria N; Yusoff NM; Zakaria Z; Lim MN; Baharuddin PJ; Fakiruddin KS; Yahaya B
    BMC Cancer; 2015 Feb; 15():84. PubMed ID: 25881239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of functional glycans between cancer stem cells and normal stem cells.
    Sasaki N; Itakura Y; Gomi F; Hirano K; Toyoda M; Ishiwata T
    Histol Histopathol; 2019 Sep; 34(9):995-1007. PubMed ID: 31025698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
    Geng S; Guo Y; Wang Q; Li L; Wang J
    Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biology and clinical implications of CD133(+) liver cancer stem cells.
    Ma S
    Exp Cell Res; 2013 Jan; 319(2):126-32. PubMed ID: 22999864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the transcription factor Sp1 suppresses colon cancer stem cell growth and induces apoptosis in vitro and in nude mouse xenografts.
    Zhao Y; Zhang W; Guo Z; Ma F; Wu Y; Bai Y; Gong W; Chen Y; Cheng T; Zhi F; Zhang Y; Wang J; Jiang B
    Oncol Rep; 2013 Oct; 30(4):1782-92. PubMed ID: 23877322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of CD44, CD117 and CD133 in identification of cancer stem cells (CSC) in oral squamous cell carcinomas (OSCC).
    Mărgăritescu C; Pirici D; Simionescu C; Stepan A
    Rom J Morphol Embryol; 2011; 52(3 Suppl):985-93. PubMed ID: 22119814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
    Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
    Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer stem cells: a biological and clinical perspective.
    Koren A; Motaln H; Cufer T
    Cell Oncol (Dordr); 2013 Jul; 36(4):265-75. PubMed ID: 23900738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.